{"id":"ceftriaxone-for-injection","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"2-5","effect":"Rash"},{"rate":"1-3","effect":"Phlebitis at injection site"},{"rate":"1-3","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ceftriaxone is a third-generation cephalosporin antibiotic that penetrates bacterial cell walls and irreversibly binds to penicillin-binding proteins, preventing the cross-linking of peptidoglycan strands essential for cell wall integrity. This leads to cell wall weakening, osmotic instability, and bacterial cell lysis. It is bactericidal and has broad-spectrum activity against gram-positive and gram-negative bacteria.","oneSentence":"Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:19.714Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, meningitis, and gonorrhea"},{"name":"Surgical prophylaxis"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT03413384","phase":"PHASE2","title":"To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BrainX Corporation","startDate":"2019-02-15","conditions":"Parkinson's Disease Dementia","enrollment":100},{"nctId":"NCT03068741","phase":"PHASE4","title":"Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Damon Scales","startDate":"2020-03-23","conditions":"Severe Sepsis or Septic Shock","enrollment":2040},{"nctId":"NCT05821478","phase":"PHASE3","title":"Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients","status":"RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-05-22","conditions":"Hidradenitis Suppurativa","enrollment":92},{"nctId":"NCT06166381","phase":"NA","title":"Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction","status":"RECRUITING","sponsor":"University of Duhok","startDate":"2024-01-25","conditions":"Infection, Bacterial","enrollment":288},{"nctId":"NCT05027516","phase":"PHASE4","title":"Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2022-01-17","conditions":"Neisseria Gonorrhoeae","enrollment":42},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT02424461","phase":"PHASE3","title":"Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-01-25","conditions":"Acute Male Urinary Tract Infection","enrollment":274},{"nctId":"NCT06220929","phase":"PHASE4","title":"Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-01-15","conditions":"Sepsis, Liver Dysfunction","enrollment":40},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":"Appendicitis Perforated","enrollment":16},{"nctId":"NCT05747807","phase":"NA","title":"Percutaneous Intradiscal Radiofrequency as A Treatment for Radicular Pain From Lumbar Disc Herniation","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2023-04-01","conditions":"Disk Herniated Lumbar, Radicular Pain, Intradiscal Radiofrequency","enrollment":18},{"nctId":"NCT05666973","phase":"NA","title":"To Compare the Skin Incision Made by the Electrocautery and Scalpel in Inguinal Hernia Repair","status":"UNKNOWN","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2023-01","conditions":"Post-operative Pain, Acute","enrollment":60},{"nctId":"NCT04268342","phase":"NA","title":"Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)","status":"UNKNOWN","sponsor":"The University of Queensland","startDate":"2022-04-26","conditions":"Drug Resistance, Microbial, Antimicrobial Stewardship, Gonorrhea","enrollment":1626},{"nctId":"NCT03294395","phase":"PHASE3","title":"New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea","status":"COMPLETED","sponsor":"Public Health Service of Amsterdam","startDate":"2017-09-18","conditions":"Gonorrhea","enrollment":346},{"nctId":"NCT03583749","phase":"","title":"Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2019-08-07","conditions":"Antimicrobials, Subcutaneous Injection, Antibiotic","enrollment":150},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT04202068","phase":"PHASE4","title":"A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2015-07-03","conditions":"Gonorrhea","enrollment":113},{"nctId":"NCT04066621","phase":"PHASE4","title":"PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2015-04-28","conditions":"Respiratory Tract Infections, Urinary Tract Infections in Children","enrollment":30},{"nctId":"NCT04056806","phase":"PHASE4","title":"2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage","status":"UNKNOWN","sponsor":"E-DA Hospital","startDate":"2019-08","conditions":"Variceal Rebleeding Rate and Infections","enrollment":100},{"nctId":"NCT02015637","phase":"PHASE3","title":"Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea","status":"TERMINATED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2014-01-23","conditions":"Gonorrhea","enrollment":460},{"nctId":"NCT03385161","phase":"NA","title":"Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-12","conditions":"Male, Ultrasonography, Botulinum Toxins, Type A","enrollment":90},{"nctId":"NCT02561442","phase":"PHASE2, PHASE3","title":"Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2015-10","conditions":"Pharmacokinetics in Healthy Adults","enrollment":18},{"nctId":"NCT00509106","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-07","conditions":"Bacterial Pneumonia","enrollment":622},{"nctId":"NCT00621504","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-01","conditions":"Bacterial Pneumonia","enrollment":606},{"nctId":"NCT02736682","phase":"PHASE4","title":"Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.","status":"COMPLETED","sponsor":"Makerere University","startDate":"2015-09","conditions":"Post Operative Infections","enrollment":174},{"nctId":"NCT00644150","phase":"NA","title":"Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2007-04","conditions":"HIV Infections, Gonorrhea, Chlamydia","enrollment":1373},{"nctId":"NCT00004216","phase":"PHASE1","title":"VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy","status":"COMPLETED","sponsor":"Vion Pharmaceuticals","startDate":"1999-08","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":""},{"nctId":"NCT00968370","phase":"PHASE4","title":"Trial in Childhood Pneumonia With Malnutrition","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2008-11","conditions":"Malnutrition, Pneumonia","enrollment":440}],"_emaApprovals":[],"_faersSignals":[{"count":22,"reaction":"NO ADVERSE EVENT"},{"count":20,"reaction":"RECALLED PRODUCT ADMINISTERED"},{"count":11,"reaction":"EXPIRED PRODUCT ADMINISTERED"},{"count":11,"reaction":"PYREXIA"},{"count":8,"reaction":"DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS"},{"count":8,"reaction":"DYSPNOEA"},{"count":8,"reaction":"HEADACHE"},{"count":8,"reaction":"HYPERSENSITIVITY"},{"count":7,"reaction":"ACUTE KIDNEY INJURY"},{"count":7,"reaction":"APLASTIC ANAEMIA"}],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Rocephin"],"phase":"marketed","status":"active","brandName":"Ceftriaxone for Injection","genericName":"Ceftriaxone for Injection","companyName":"The University of Queensland","companyId":"the-university-of-queensland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan. Used for Bacterial infections including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, meningitis, and gonorrhea, Surgical prophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}